| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/14/1997 | EP0773222A1 Novel carbapenem derivative |
| 05/14/1997 | EP0773221A1 Stable crystalline tetrahydrofolic acid salts |
| 05/14/1997 | EP0773217A1 Benzothiphene derivatives for treating resistant tumors |
| 05/14/1997 | EP0773214A1 Trifluoromethylquinolinecarboxylic acid derivative |
| 05/14/1997 | EP0773029A1 Hepatitis c virus proliferation inhibitor |
| 05/14/1997 | EP0773028A1 Percutaneously absorbable preparation |
| 05/14/1997 | EP0773027A1 Use of azacyclic or azabicyclic pyrazine compounds for treating anxiety |
| 05/14/1997 | EP0773026A2 NK-1 receptor antagonists for the treatment of cancer |
| 05/14/1997 | EP0773025A1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process |
| 05/14/1997 | EP0773024A2 Use of N-substituted nicotinamide compounds for the treatment of acute and chronic inflammatory diseases |
| 05/14/1997 | EP0773023A1 New uses for corticotropin releasing factor (CRF) antagonists |
| 05/14/1997 | EP0773022A2 Pharmaceutical composition for the treatment of rhinitus, containing sympathomometic and pantothenol and/or pantothenic acid |
| 05/14/1997 | EP0773021A1 Use of azacyclic or azabicyclic oxadiazole compounds for treating anxiety |
| 05/14/1997 | EP0773020A2 Pharmaceutical compositions containing L-carnitine or derivatives thereof in combination with resveratrol or derivatives thereof, for the prophylaxis and treatment of cardiovascular disorders, peripheral vascular diseases and peripheral diabetic neuropathy |
| 05/14/1997 | EP0773019A1 Hyperlipemia remedy |
| 05/14/1997 | EP0772681A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 05/14/1997 | EP0772625A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 05/14/1997 | EP0772622A1 5'-dithio-modified oligonucleotides |
| 05/14/1997 | EP0772621A2 Oligonucleotides with anti-mdr-1 gene activity |
| 05/14/1997 | EP0772620A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772617A1 7-o-carbamoyl heptose derivatives, process for their production and their use and screening process for their detection |
| 05/14/1997 | EP0772615A1 IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 05/14/1997 | EP0772614A1 Halogenated imidazopyridines |
| 05/14/1997 | EP0772613A2 Process for the production of aminoazobicycloalkanes from oximes |
| 05/14/1997 | EP0772612A1 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists |
| 05/14/1997 | EP0772611A1 Piperazine thiopyridines for controlling helicobacter bacteria |
| 05/14/1997 | EP0772610A1 Dihydrobenzofuranes |
| 05/14/1997 | EP0772607A1 Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same |
| 05/14/1997 | EP0772606A1 Substituted thiazoles for the treatment of inflammation |
| 05/14/1997 | EP0772605A1 Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes |
| 05/14/1997 | EP0772604A1 Triazole compounds and their use as dopamine-d 3?-ligands |
| 05/14/1997 | EP0772603A1 Substituted pyrimidine compounds and their use |
| 05/14/1997 | EP0772600A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 05/14/1997 | EP0772598A1 Heterocyclic- and carbocyclic-substituted benzoic acids and synthesis thereof |
| 05/14/1997 | EP0772597A1 3,4-substituted pyrazoles for the treatment of inflammation |
| 05/14/1997 | EP0772596A1 INDOLIZINE sPLA2 INHIBITORS |
| 05/14/1997 | EP0772595A1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof |
| 05/14/1997 | EP0772594A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 05/14/1997 | EP0772593A1 Thiopyridyl compounds for controlling helicobacter bacteria |
| 05/14/1997 | EP0772592A1 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS |
| 05/14/1997 | EP0772585A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0772454A1 Antisense oligonucleotides against hepatitis b viral replication |
| 05/14/1997 | EP0772446A1 Anti-adhesion agent |
| 05/14/1997 | EP0772445A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 05/14/1997 | EP0772444A1 Use of the enantiomers of oxazophosphorines, e.g. ifosfamide, in anti-tumour therapy, for reducing side-effects |
| 05/14/1997 | EP0772442A1 Use of immunosuppressive agents for the treatment of schizophrenia |
| 05/14/1997 | EP0772441A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 05/14/1997 | EP0772440A1 Carbon monoxide dependent guanylyl cyclase modifiers |
| 05/14/1997 | EP0772439A1 Novel antibiotic compounds and methods to treat gram-positive bacterial and mycoplasmal infections |
| 05/14/1997 | EP0772438A1 Methods of reducing scarring in wound healing |
| 05/14/1997 | EP0772396A1 Method of regulating immune function |
| 05/14/1997 | EP0650365B1 Biocidal composition containing mustard seed plant extract |
| 05/14/1997 | EP0629209B1 Sugar derivatives of macrolides |
| 05/14/1997 | EP0536255B1 Ophthalmic suspensions |
| 05/14/1997 | EP0514449B1 Novel anti-tumoral agent derived from dextran |
| 05/14/1997 | EP0505389B1 Antiparasitic composition for animal use |
| 05/14/1997 | EP0441852B1 Muscarinic receptor antagonists |
| 05/14/1997 | CN1149874A Cephalosporin antibiotics |
| 05/14/1997 | CN1149873A Piperazine derivatives as 5HT1A antagonists |
| 05/14/1997 | CN1149870A Substituted pyrazoles having corticotropin-releasing factor (CRF) antagonist activity |
| 05/14/1997 | CN1149869A Substituted sulfonamides as selective beta3 agonists for treatment of diabetes and obesity |
| 05/14/1997 | CN1149866A Compounds containing michael-acceptor, especially maleimide or maleic acid derivatives, directly or indirectly linked to chromophore |
| 05/14/1997 | CN1149836A Tin-117m-containing radio therapeutic agents |
| 05/14/1997 | CN1149833A Acylated enol derivatives as prodrugs of elastase inhibitors |
| 05/14/1997 | CN1149831A Controlled-release dosage forms of azithromycin |
| 05/14/1997 | CN1149830A Pyridylbisphosphonates for use as therapeutical agent |
| 05/14/1997 | CN1149829A Polymer coated tablet comprising amoxycillin and clavulanate |
| 05/14/1997 | CN1149827A Agonists and antagonists of nicotinic acetylcholine receptors of insects to control endoparasites |
| 05/14/1997 | CN1149587A Ginseng oligosaccharide element and ginseng monomer oligosaccharide and its preparing technology and use |
| 05/14/1997 | CN1149583A Enderma agent receptor antagonist |
| 05/14/1997 | CN1149476A Ningshen medicinal composition for curing chronic retraction psychosis |
| 05/14/1997 | CN1149471A Nutrient for youngsters |
| 05/14/1997 | CN1149457A 复方庆大霉素注射液 Compound gentamicin injection |
| 05/14/1997 | CN1149456A New medical use for cucoline |
| 05/14/1997 | CN1149455A Compound amino acid primary liquid containing active calcium and sulphur |
| 05/14/1997 | CN1149454A Method for curing tinnitus by nerve protecting agent |
| 05/14/1997 | CN1149453A Animal growth promoting composition |
| 05/14/1997 | CN1034868C Preparing method for 6 alpha, 9 alpha-difluorido-progester-3,20-diones compound |
| 05/14/1997 | CN1034865C Preparing method for 2-aminopyrimidinone |
| 05/13/1997 | US5629454 Conformationally locked nucleoside analogues |
| 05/13/1997 | US5629436 Use of N-arylmethylene ethylenediaminetriacetates N-arylmethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress |
| 05/13/1997 | US5629431 Inhibitors of retroviral proteases |
| 05/13/1997 | US5629430 Anticarcinogenic agents |
| 05/13/1997 | US5629425 Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene |
| 05/13/1997 | US5629413 Oligonucleotides with activity against human immunodeficiency virus |
| 05/13/1997 | US5629412 Polypeptide and carbohydrate |
| 05/13/1997 | US5629349 Compounds for modulating growth of infectious agents |
| 05/13/1997 | US5629347 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 05/13/1997 | US5629345 Sulfonylurea |
| 05/13/1997 | US5629344 Promoting epithelialization and hydration, decreasing fibroblast action and softening keratin by applying to eye surface a preparation of urea or its derivatives; treating ocular scarring and irritations with the ureas |
| 05/13/1997 | US5629341 N-chlorophenyl carbamates and dithiocarbamates; hiv, herpes, influenza and rhinoviruses; side effect reduction; |
| 05/13/1997 | US5629340 Angiogenesis inhibitor and novel compound |
| 05/13/1997 | US5629339 Chronic venous insufficiency |
| 05/13/1997 | US5629338 Tannins and lipase inhibitors containing the same as active ingredients |
| 05/13/1997 | US5629337 Methods for treating asthma using optically pure (-)-zileuton |
| 05/13/1997 | US5629336 Use of glycine/NMDA receptor ligands for the treatment of drug dependence and withdrawal |
| 05/13/1997 | US5629333 Method treating cognitive disorders using optically pure R(+) ondansetron |
| 05/13/1997 | US5629331 2-butyl-3-tetrazolylbiphenylylmethyl-1,3-diazaspirononenone made by reacting corresponding nitrile with alkaline azide and triethylamine hydrochloride in inert polar aprotic solvent, neutralizing salt, crystallizing in one of two ways |